10-Q Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001564590-22-004673`
Period End Date	20211231
Filing Date	20220211
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	tyme-10q_20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 71 Cash Flow Statement 49 Stockholders Equity 40

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$107.52M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$54.26M	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$639.61K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$987.47K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.15M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$848.50K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$76.55M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$109.66M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$530.99K	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$47.95K	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$75.47K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$16.41M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$110.26M	USD	Point-in-time
Total assets	`Assets`	$93.00M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	172.21M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	172.20M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	172.20M	shares	Point-in-time
Accounts payable and other current liabilities (including $46,000 and $87,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.84M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	172.21M	shares	Point-in-time
Accounts payable and other current liabilities (including $46,000 and $87,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.84M	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$457.31K	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$726.03K	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.04M	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.11M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$34.66K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$40.07K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.45M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.64M	USD	Point-in-time
Severance payable, net of current portion	`SeverancePayableNoncurrent`	$850.71K	USD	Point-in-time
Severance payable, net of current portion	`SeverancePayableNoncurrent`	$537.37K	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$7.81K	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$41.26K	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$1.93M	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$312.52K	USD	Point-in-time
Total liabilities	`Liabilities`	$6.31M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.47M	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 172,206,894 issued and outstanding at December 31, 2021, 300,000,000 authorized, 172,200,644 issued and outstanding at March 31, 2021	`CommonStockValue`	$17.22K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 172,206,894 issued and outstanding at December 31, 2021, 300,000,000 authorized, 172,200,644 issued and outstanding at March 31, 2021	`CommonStockValue`	$17.22K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$240.44M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$238.57M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-164.20K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-153.61M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-136.79M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$96.48M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$91.51M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$86.69M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$19.03M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$101.80M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.17M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$93.00M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$110.26M	USD	Point-in-time

Income Statement 71 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	3 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$313.00K	USD	3 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$109.00K	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$450.00K	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$47.00K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.46M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$12.97M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$11.14M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.55M	USD	1 Quarter
General and administrative (including $47,000, $109,000, $313,000 and $450,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$7.99M	USD	3 Qtrs
General and administrative (including $47,000, $109,000, $313,000 and $450,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$2.42M	USD	1 Quarter
General and administrative (including $47,000, $109,000, $313,000 and $450,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$2.32M	USD	1 Quarter
General and administrative (including $47,000, $109,000, $313,000 and $450,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$7.33M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$18.47M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$20.96M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$5.87M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.89M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-20.96M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-18.47M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.89M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.87M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-550.10K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.62M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$3.00M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$228.75K	USD	1 Quarter
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	$94.65K	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	$19.06K	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	$1.54K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$36.12K	USD	1 Quarter
Interest expense	`InterestExpense`	$56.93K	USD	3 Qtrs
Interest expense	`InterestExpense`	$77.89K	USD	3 Qtrs
Interest expense	`InterestExpense`	$16.31K	USD	1 Quarter
Interest expense	`InterestExpense`	$22.54K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$1.66M	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$569.91K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-832.59K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-249.75K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.80M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.81M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.85M	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.17	USD	3 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	3 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	130.17M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	172.21M	shares	3 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	172.21M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	127.61M	shares	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.80M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.81M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.85M	USD	1 Quarter
Unrealized loss on marketable securities, net of tax	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-164.20K	USD	3 Qtrs
Unrealized loss on marketable securities, net of tax	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-105.64K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-16.98M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.42M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-21.80M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-6.12M	USD	1 Quarter

Cash Flow Statement 49 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-16.81M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-21.80M	USD	3 Qtrs
Depreciation	`Depreciation`	$3.89K	USD	3 Qtrs
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$1.86M	USD	3 Qtrs
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$2.74M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-550.10K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.62M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$3.00M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$228.75K	USD	1 Quarter
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	3 Qtrs
Net amortization of premiums and discounts on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.19M	USD	3 Qtrs
Loss on call redemption of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-1.42K	USD	3 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$301.76K	USD	3 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$-878.85K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-711.39K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-973.25K	USD	3 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-141.50K	USD	3 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-27.52K	USD	3 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.12K	USD	3 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$175.23K	USD	3 Qtrs
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-582.06K	USD	3 Qtrs
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-277.30K	USD	3 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-623.47K	USD	3 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$71.08K	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-44.42K	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-28.03K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-18.50M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-14.04M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$89.57M	USD	3 Qtrs
Proceeds from maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$16.88M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-72.69M	USD	3 Qtrs
Insurance note payments	`InsuranceNotePayments`	$518.12K	USD	3 Qtrs
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$5.81M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$6.19K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.19K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.29M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-13.21M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-86.71M	USD	3 Qtrs
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.49M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$107.52M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$20.80M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.49M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$107.52M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$20.80M	USD	Point-in-time
Interest	`InterestPaidNet`	$77.89K	USD	3 Qtrs
Interest	`InterestPaidNet`	$56.93K	USD	3 Qtrs
Operating lease right-of-use asset obtained in exchange for lease liabilities.	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$75.44K	USD	3 Qtrs

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$96.48M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$15.83M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$91.51M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$86.69M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$14.50M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$101.80M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$9.17M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	172.20M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	172.21M	shares	Point-in-time
Proceeds from the exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.19K	USD	1 Quarter
Proceeds from the exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	6,250.00	shares	3 Qtrs
Warrant to share exchange	`StockIssuedDuringPeriodValueWarrantToShareExchange`	$3.39M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$784.89K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$643.66K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$616.23K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$604.44K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$883.93K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.07M	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-105.64K	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-33.84K	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-24.71K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.80M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.81M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.85M	USD	1 Quarter
Balance, at end	`StockholdersEquity`	$96.48M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$15.83M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$91.51M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$86.69M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$14.50M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$101.80M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$9.17M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	172.20M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	172.21M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.